50 completed, 6 terminated, 3 not yet recruiting, 3 recruiting. 66 Phase 3, 18 Phase 2.
Follow Autistic Disorder: new trials by email Literature Review of Autistic Disorder trials Research Report on Autistic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | Phase 2 / Phase 3 | Not yet recruiting | Spinogenix | 120 | 2026-12-01 | 2026-10-09 |
| NTI164 in Autism Spectrum Disorder NTI164, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Not yet recruiting | Fenix Innovation Group | 200 | 2026-09-30 | 2026-09-30 |
| Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations Everolimus blinded oral capsules, Placebo - Cowden's Disease, Cowden's Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Boston Children's Hospital | 60 | 2026-09-01 | 2026-06-04 |
| A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents KarXT, KarX-EC - Schizophrenia, Autism-Related Irritability | Phase 3 | Recruiting | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 400 | 2026-04-07 | 2026-11-06 |
| Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders amitriptyline - Autism Spectrum Disorder, Repetitive Compulsive Behavior | Phase 3 | Terminated | University of Missouri, Kansas City | 1 | 2023-11-01 | 2025-05-30 |
| Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders PostbiotiX Comfort®, Control - Autism, Autism Disorder | Phase 2 / Phase 3 | Recruiting | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 90 | 2023-03-21 | 2026-03-04 |
| Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency) Lithium Carbonate, Placebo - Autism Spectrum Disorder | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 22 | 2022-02-21 | 2025-10-02 |
| Role of Bumetanide in Treatment of Autism Bumetanide, Placebo - Autism | Phase 3 | Recruiting | Sherief Abd-Elsalam | 80 | 2021-01-01 | 2021-02-23 |
| Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 Brexpiprazole - Irritability Associated With Autism Spectrum Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 95 | 2020-01-23 | 2024-05-30 |
| The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder Cannabis oil - Autism Spectrum Disorder | Phase 3 | Completed | Assaf-Harofeh Medical Center | 128 | 2019-11-14 | 2024-07-31 |
| Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder Brexpiprazole, Placebo - Irritability Associated With Autism Spectrum Disorder (ASD) | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 119 | 2019-10-30 | 2025-08-28 |
| Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions Memantine Hydrochloride, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Terminated | Massachusetts General Hospital | 25 | 2018-11-13 | 2026-02-25 |
| Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder Aripiprazole Oral Solution, Placebo Oral Solution - Autistic Disorder | Phase 3 | Completed | Otsuka Beijing Research Institute | 111 | 2018-04-09 | 2020-12-29 |
| Intranasal Vasopressin Treatment in Children With Autism Vasopressin (USP) Injectable Solution [Vasostrict], Placebo - Autism, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Stanford University | 157 | 2018-02-20 | 2026-06-04 |
| Open Label of Clinical Trial of Sulforaphane in Children With Autism Sulforaphane - Autism | Phase 3 | Completed | University of California, San Francisco | 21 | 2016-01-01 | 2019-03-06 |
| An Open Label Study of CM-AT for the Treatment of Children With Autism CM-AT - Autism | Phase 3 | Active not recruiting | Curemark | 405 | 2015-10-01 | 2026-03-18 |
| Cortical Metrics in Intervention Trials With Autism Spectrum Disorders Dextromethophan - Autism Spectrum Disorders | Phase 2 / Phase 3 | Withdrawn | Duke University | 2015-08-01 | 2016-08-25 | |
| Oxytocin in Adolescents With Autism Spectrum Disorders OCYTOCINA - SPRAY NASAL - Autism Spectrum Disorder | Phase 2 / Phase 3 | Terminated | University of Sao Paulo General Hospital | 30 | 2015-06-01 | 2019-10-28 |
| A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) CM-AT, PLACEBO - Autism | Phase 3 | Completed | Curemark | 190 | 2015-05-13 | 2023-05-24 |
| Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD) Auditory-Motor Mapping Training, Speech-Repetition Therapy - Autism | Phase 2 / Phase 3 | Completed | Beth Israel Deaconess Medical Center | 14 | 2014-11-01 | 2020-05-19 |
Showing 20 of 66. Sign in to see all of them.
Autism Spectrum Disorder (21) · Child Development Disorders, Pervasive (5) · Asperger Syndrome (4) · Attention Deficit Disorder with Hyperactivity (2) · Behavioral Symptoms (2) · Marijuana Abuse (2) · Problem Behavior (2) · Schizophrenia (2) · Aggression (1) · Anxiety Disorders (1) · Anxiety, Separation (1) · Bipolar Disorder (1) · Communication (1) · Developmental Disabilities (1)
Mental Disorders (66) · Neurodevelopmental Disorders (66) · Child Development Disorders, Pervasive (61) · Autism Spectrum Disorder (45) · Behavior (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Heredodegenerative Disorders, Nervous System (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Attention Deficit and Disruptive Behavior Disorders (2) · Behavioral Symptoms (2) · Chemically-Induced Disorders (2) · Child Behavior (2)
Aripiprazole (7) · Risperidone (4) · Cycloserine (3) · Secretin (3) · Bumetanide (2) · Everolimus (2) · Fluoxetine (2) · Lurasidone Hydrochloride (2) · Methylphenidate (2) · Sugars (2) · Vitamin B 12 (2) · brexpiprazole (2) · mecobalamin (2) · Acupuncture Therapy (1) · Amitriptyline (1)
University of California, San Francisco (6) · Otsuka Pharmaceutical Development & Commercialization, Inc. (5) · Curemark (4) · Indiana University (4) · The University of Hong Kong (4) · Massachusetts General Hospital (3) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Neuropharm (2) · Otsuka Pharmaceutical Co., Ltd. (2) · Repligen Corporation (2) · Sumitomo Pharma America, Inc. (2) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Beth Israel Deaconess Medical Center (1) · Boston Children's Hospital (1)
United States (43) · France (4) · Hong Kong (4) · Japan (4) · Australia (2) · Canada (2) · Hungary (2) · Mexico (2) · Poland (2) · Puerto Rico (2) · Romania (2) · Spain (2) · Brazil (1) · Bulgaria (1) · China (1)
Wong Virginia (4) · Christopher J. McDougle, MD (3) · Robert Hendren, DO (3) · Robert L Hendren, DO (3) · Deborah Pearson, PhD (2) · Abeer Salamah, Dr (1) · Alan Unis, MD (1) · Antonio Y. Hardan, M.D. (1) · Benedetto Vitiello, NIMH Coordinator (1) · Christopher J McDougle (1) · Christopher J. McDougle, M.D. (1) · Craig A. Erickson, M.D. (1) · David Dunn, MD (1)
PMID 37811711, PMID 21731831, PMID 24138011, PMID 33583058, PMID 38032645, PMID 15492353, PMID 20973712, PMID 21663425, PMID 21813076, PMID 21818676, PMID 23233021, PMID 23357440, PMID 25878901, PMID 26746121, PMID 26770664, PMID 26802979, PMID 26889605, PMID 28138381, PMID 28941259, PMID 29854372, PMID 31217257, PMID 31267292, PMID 34324397, PMID 35241779, PMID 36006807, PMID 37267443
2018 (1), 2025 (1), K08MH001516 (1), K23MH068627 (1), P01HD035465 (1), P01HD035468 (1), R01HD091972 (1), R01MH072263 (1), R01MH072961 (1), R01MH073524 (1), R01MH077600 (1), R21MH080026 (1), U01NS061264 (1)